U
Turn Therapeutics Inc. TTRX
$3.53 $0.030.86% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2025 06/30/2025 09/30/2024
Total Cash And Short-Term Investments -2.62% 265.56% --
Total Receivables -- -- --
Inventory -- -- --
Prepaid Expenses -7.55% -- --
Finance Division Loans and Leases Current -- -- --
Total Finance Division Other Current Assets -- -- --
Other Current Assets -- -- --
Total Current Assets -2.93% -- --

Total Current Assets -2.93% -- --
Net Property, Plant & Equipment -10.60% -- --
Long-term Investments -- -- --
Goodwill -- -- --
Total Other Intangibles 9.18% -- --
Finance Div Loans & Leases LT -- -- --
Total Finance Div Other LT Assets -- -- --
Total Other Assets 0.00% -- --
Total Assets -0.78% -- --

Total Accounts Payable 122.59% -- --
Total Accrued Expenses -- -- --
Short-term Debt -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- --
Finance Division Debt Current 3.23% -- --
Total Finance Division Other Current Liabilities -- -- --
Total Other Current Liabilities -- -- --
Total Current Liabilities 117.69% -- --

Total Current Liabilities 117.69% -- --
Long-Term Debt -- -- --
Short-term Debt -- -- --
Capital Leases -20.17% -- --
Finance Division Debt Non Current -- -- --
Total Finance Division Other Non Current Liabilities -- -- --
Total Other Liabilities 0.00% -- --
Total Liabilities 48.37% -- --

Common Stock & APIC 0.17% -- --
Retained Earnings -9.17% -- --
Treasury Stock & Other 91.86% -- --
Total Common Equity -71.60% 1,100.28% --

Preferred Stock Redeemable -- -- --
Preferred Stock Non Redeemable -- -- --
Preferred Stock Convertible -- -- --
Preferred Stock, Others -- -- --
Total Preferred Equity -- -- --

Total Common Equity -71.60% 1,100.28% --
Total Preferred Equity -- -- --
Total Minority Interest -- -- --
Total Equity -71.60% 1,100.28% --